Literature DB >> 28238883

A bicentre retrospective study of features and outcomes of patients with reactive arthritis.

Audrey Courcoul1, Anne Brinster2, Evelyne Decullier3, Jean-Paul Larbre4, Muriel Piperno4, Eric Pradat5, Jacques G Tebib1, Daniel Wendling2, Fabienne Coury6.   

Abstract

OBJECTIVE: Reactive arthritis (ReA) is a sterile arthritis following an extra-articular infection, usually of the gastrointestinal or genitourinary tract. The aim of this study was to assess the incidence and the clinical and therapeutic characteristics of ReA and to compare them with those of a historical cohort. We hypothesised that improved hygiene together with prevention and treatment of sexually transmitted infections may have decreased the incidence of ReA.
METHODS: All patients with ReA diagnosed in the University Hospital Centres of Lyon Sud and Besançon from January 2002 to December 2012 were included in the study retrospectively and were compared with ReA patients diagnosed from January 1986 to December 1996 in the same two hospitals. Medical records were reviewed, clinical features, treatments and outcomes were analysed and diagnoses were compared with international diagnostic criteria.
RESULTS: Twenty-seven patients were included between 2002 and 2012 compared with 31 between 1986 and 1996. The overall incidence of ReA in patients hospitalised in the rheumatology department did not change, although the current evolution is more severe with development of chronic disease in the form of more frequent spondyloarthritis. While the incidence of Chlamydiae trachomatis has decreased, new microbes are now found to be involved.
CONCLUSIONS: ReA still exists and its incidence has been stable over the last 30 years. However, ReA currently more often progress to spondyloarthritis. Our study also highlights the need for diagnostic criteria that accurately detect ReA.
Copyright © 2017 Société française de rhumatologie. Published by Elsevier SAS. All rights reserved.

Entities:  

Keywords:  Infection; Outcome; Reactive arthritis; Spondyloarthritis

Mesh:

Substances:

Year:  2017        PMID: 28238883     DOI: 10.1016/j.jbspin.2017.01.013

Source DB:  PubMed          Journal:  Joint Bone Spine        ISSN: 1297-319X            Impact factor:   4.929


  7 in total

1.  Epidemiology: Time to revisit the concept of reactive arthritis.

Authors:  Ramnath Misra; Latika Gupta
Journal:  Nat Rev Rheumatol       Date:  2017-05-11       Impact factor: 20.543

Review 2.  Reactive Arthritis Update: Spotlight on New and Rare Infectious Agents Implicated as Pathogens.

Authors:  Henning Zeidler; Alan P Hudson
Journal:  Curr Rheumatol Rep       Date:  2021-07-01       Impact factor: 4.592

3.  Fever as an initial manifestation of spondyloarthritis: A retrospective study.

Authors:  Se Jin Byun; William Han Bae; Seung Min Jung; Sang-Won Lee; Yong-Beom Park; Jason Jungsik Song
Journal:  PLoS One       Date:  2017-09-14       Impact factor: 3.240

Review 4.  Reactive Arthritis: Update.

Authors:  Ibtissam Bentaleb; Kawther Ben Abdelghani; Samira Rostom; Bouchra Amine; Ahmed Laatar; Rachid Bahiri
Journal:  Curr Clin Microbiol Rep       Date:  2020-09-26

5.  Approaching Reactive Arthritis Associated With Poor Prognostic Factors: A Case Report and Literature Review.

Authors:  Swetha Ann Alexander; Eunjung Kim; Ranadeep Mandhadi
Journal:  Cureus       Date:  2021-02-25

Review 6.  Reactive arthritis before and after the onset of the COVID-19 pandemic.

Authors:  Dana Bekaryssova; Marlen Yessirkepov; Olena Zimba; Armen Yuri Gasparyan; Sakir Ahmed
Journal:  Clin Rheumatol       Date:  2022-03-05       Impact factor: 3.650

7.  Association between high mobility group box 1 protein and juvenile idiopathic arthritis: a prospective longitudinal study.

Authors:  Dan Xu; Yu Zhang; Zhi-Yong Zhang; Xue-Mei Tang
Journal:  Pediatr Rheumatol Online J       Date:  2021-07-12       Impact factor: 3.054

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.